Publications



Drain use in pancreatic surgery: Results from an international survey among experts in the field


Pergolini, I., Schorn, S., Goess, R., Novotny, A. R., Ceyhan, G. O., Friess, H., International Pancreatic Surgery, C., and Demir, I. E. (2022). Surgery 172, 265-272. doi: 10.1016/j.surg.2021.11.023

Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review


Vornhulz, M., Anton, S., Eross, B., Szakacs, Z., Hegyi, P., Regel, I., Belka, C., Niyazi, M., Mayerle, J., and Beyer, G. (2022). Radiat Oncol 17, 108. doi: 10.1186/s13014-022-02076-5

ChipCytometry for multiplexed detection of protein and mRNA markers on human FFPE tissue samples


Jarosch, S., Kohlen, J., Wagner, S., D'Ippolito, E., and Busch, D. H. (2022). STAR Protoc 3, 101374. doi: 10.1016/j.xpro.2022.101374

MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree


Bollwein, C., Gonalves, J. P. L., Utpatel, K., Weichert, W., and Schwamborn, K. (2022). Molecules 27. doi: 10.3390/molecules27113464

Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype


Orben, F., Lankes, K., Schneeweis, C., Hassan, Z., Jakubowsky, H., Krauss, L., Boniolo, F., Schneider, C., Schafer, A., Murr, J., Schlag, C., Kong, B., Ollinger, R., Wang, C., Beyer, G., Mahajan, U. M., Xue, Y., Mayerle, J., Schmid, R. M., Kuster, B., Rad, R., Braun, C. J., Wirth, M., Reichert, M., Saur, D., and Schneider, G. (2022). JCI Insight 7. doi: 10.1172/jci.insight.151353

Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment


Roy-Luzarraga, M., Reynolds, L. E., de Luxan-Delgado, B., Maiques, O., Wisniewski, L., Newport, E., Rajeeve, V., Drake, R. J. G., Gomez-Escudero, J., Richards, F. M., Weller, C., Dormann, C., Meng, Y. M., Vermeulen, P. B., Saur, D., Sanz-Moreno, V., Wong, P. P., Geraud, C., Cutillas, P. R., and Hodivala-Dilke, K. (2022). Cancer Res 82, 1909-1925. doi: 10.1158/0008-5472.CAN-20-3807

Single-cell profiling guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphoma


Kramer, O. H., and Schneider, G. (2022). Clin Transl Med 12, e858. doi: 10.1002/ctm2.858

Detecting drug resistance in pancreatic cancer organoids guides optimized chemotherapy treatment


Hennig, A., Baenke, F., Klimova, A., Drukewitz, S., Jahnke, B., Bruckmann, S., Secci, R., Winter, C., Schmache, T., Seidlitz, T., Bereuter, J. P., Polster, H., Eckhardt, L., Schneider, S. A., Bruckner, S., Schmelz, R., Babatz, J., Kahlert, C., Distler, M., Hampe, J., Reichert, M., Zeissig, S., Folprecht, G., Weitz, J., Aust, D., Welsch, T., and Stange, D. E. (2022). J Pathol [Epub ahead of print]. doi: 10.1002/path.5906

Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6


Kidger, A. M., Saville, M. K., Rushworth, L. K., Davidson, J., Stellzig, J., Ono, M., Kuebelsbeck, L. A., Janssen, K. P., Holzmann, B., Morton, J. P., Sansom, O. J., Caunt, C. J., and Keyse, S. M. (2022). Oncogene 41, 2811-2823. doi: 10.1038/s41388-022-02302-0

Perseus plugin "Metis" for metabolic-pathway-centered quantitative multi-omics data analysis for static and time-series experimental designs


Hamzeiy, H., Ferretti, D., Robles, M. S., and Cox, J. (2022). Cell Rep Methods 2, 100198. doi: 10.1016/j.crmeth.2022.100198